Description
This training provides knowledge on xylazine, a CNS depressant, linked to an increasing number of overdose deaths in the US. This describes the physiologic effects of xylazine, manifestations of xylazine intoxication, overdose, communicable infections associated with xylazine use, and wound care for persons injecting xylazine.
NOTE: This training is 60 minutes long. There will be an optional 30-minute Q&A session following the training, which will not count for credit.
Objectives
Following this training, participants will have the knowledge to:
- Describe the physiologic effects of xylazine.
- Recognize manifestations of intoxication in persons using xylazine.
- Recall signs of xylazine overdose and appropriate response.
- Identify common skin and soft tissue infections associated with xylazine use.
- Describe practices to decrease risk of skin and soft tissue infections in persons using xylazine.
- Recall methods of wound care for persons injecting xylazine.
Sponsored by
Boston Medical Center Grayken Center for Addiction TTA, Massachusetts Department of Public Health, Bureau of Substance Addiction Services (DPH/BSAS), Opioid Response Network (ORN)
Funding for this initiative was made possible (in part) by grant no. 1H79TI085588-02 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
Accreditation information
Please read the Accreditation Information section of the
training page to learn more.
Audience
Providers, nurses, social workers, psychologists, peer supports, other clinical staff, and non-clinicians.
